| Enrique Madrigal-segura, MD | |
|
1629 K St Nw, Suite 300, Washington, DC 20006-1602 | |
| (866) 564-3135 | |
| Not Available |
| Full Name | Enrique Madrigal-segura |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1629 K St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184931057 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 25252 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Enrique Madrigal-segura, MD 1503 Terra Oaks Ct, Mount Airy, MD 21771-7470 Ph: (866) 564-3135 | Enrique Madrigal-segura, MD 1629 K St Nw, Suite 300, Washington, DC 20006-1602 Ph: (866) 564-3135 |
News Archive
California's new insurance commissioner sought Monday to force health insurers to spend more of their revenue on medical care. In his first official act, Insurance Commissioner Dave Jones ordered emergency regulations requiring insurance companies to devote at least 80% of their income to policyholders' claims in the state's individual insurance market (Helfand, 1/4).
EpiCept Corporation today announced that it has filed for Fast Track designation for AmiKet(amitriptyline 4%, ketamine 2% cream) for the treatment for chemotherapy-induced peripheral neuropathy (CIPN) with the U.S. Food and Drug Administration.
Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced that the U.S. Patent and Trademark Office (US PTO) has expanded the intellectual property protections enabled by a previously issued patent that is central to Neurologix's Parkinson's disease program. The new allowances to U.S. Patent Number 765,446, entitled "Glutamic acid decarboxylase (GAD) based delivery systems," broaden the patent's coverage beyond Parkinson's disease to include the use of GAD65 in the treatment of other neurological and related disorders.
Lyfebulb, the International Pemphigus Pemphigoid Foundation (IPPF) and Immune Pharmaceuticals Inc., announced a collaboration to increase awareness of unmet needs in treating bullous pemphigoid last night at an event attended by more than sixty patients, physicians, scientists and other interested parties.
› Verified 5 days ago
Mr. Joel Edward Kleinman, M.D., PH.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3734 Jenifer St Nw, Washington, DC 20015 Phone: 202-363-4846 Fax: 202-363-2025 | |
Dr. John Shill, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2220 20th St Nw, Ste 71, Washington, DC 20009 Phone: 202-320-4417 | |
Nubia Amparo Chong, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1300 I St Nw Ste 400e, Washington, DC 20005 Phone: 202-902-7324 Fax: 848-213-0063 | |
Dr. Jerrold Thomas O'rourke Jr., M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1330 New Hampshire Ave Nw, Ste 113, Washington, DC 20036 Phone: 202-463-6634 Fax: 202-463-6638 | |
Dr. Jaime Suarez, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2401 E Street Nw - M/med/qi - Sa-1, Department Of State, Washington, DC 20522 Phone: 202-663-2453 Fax: 202-663-3247 | |
Dr. Estela M. Gonzalez, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2333 Ontario Rd Nw, Washington, DC 20009 Phone: 202-420-7121 | |
Dr. Richard Martin Restak, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1800 R St Nw, Suite C-3, Washington, DC 20009 Phone: 202-462-0455 Fax: 202-462-0340 |